14.4K
Downloads
70
Episodes
The Off Script podcast offers in-depth interviews and discussions with industry experts about hot-button topics in pharma, and goes behind the scenes of Pharma Manufacturing’s print and online coverage, which follows the industry’s biggest issues surrounding scale-up, technology innovations, regulations and more
Episodes
![FDA approves Adaptimmune therapy, halts vTv diabetes program; Sanofi sues Sarepta over Duchenne patents [The good, the bad, the ugly]](https://pbcdn1.podbean.com/imglogo/image-logo/9655061/Security_14__hjvhxj_300x300.jpg){kind=logo}
Monday Aug 05, 2024
Monday Aug 05, 2024
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week:
The good — FDA approves Adaptimmune engineered cell therapy
The bad — FDA puts clinical hold on vTv Therapeutics diabetes program
The ugly — Sanofi sues Sarepta over manufacturing patents for Duchenne gene therapy